Harvard Bioscience Unveils Strategic Transformation Toward Translational Tools

Endpoints NewsAardvark's next move after clinical hold; Alumis' verdict on Acelyrin asset

FierceBiotechWhy Model Medicines needs to ‘discover new colors’ in its AI drug discovery quest

BioWorldSanofi identifies YAP1/TEAD and TAZ/TEAD interaction inhibitors

BioWorldCSPC Megalith Biopharmaceutical discloses new CDCP1-targeting ADCs

BioWorldAntelope Therapeutics patents new antibody-drug conjugates for cancer

BioWorldHangzhou Institute of Medicine discovers new CDK2/cyclin E1 inhibitors

BioWorldNew KRAS mutant inhibitors reported in Université de Montréal patent

PharmaVoiceFormer Ovid CEO Dr. Jeremy Levin’s rallying cry for biotech

Endpoints NewsM&A isn’t just for big pharma. Mid-size companies are stepping up deal hunts

LabiotechCAR-T therapy for stiff person syndrome nears approval

IlluminaHere Are Friday’s Top Wall Street Analyst Research Calls: Arista Networks, BWX Technologies, Cisco Systems, Danaher, Doximity, Estee Lauder, Illumina, Texas Roadhouse, Workday, and More - 24/7 Wall St.

Endpoints NewsAndrea Pfeifer ends 23-year reign at AC Immune; Acadia's top R&D exec announces retirement